Comments
Pharma major Dr Reddy’s Laboratories has initiated recall of five lots of Ranitidine Hydrochloride tablets from the US market.
The over-the-counter drug, indicated for treatment of gastric disorders, was being recalled voluntarily due to microbial contamination of non-sterile products, according to a US Food and Drug Administration (USFDA) notification.
When contacted, a spokesperson of the Hyderabad-based company told Business Line that the financial impact of recall was ``minimal’’ as it was limited to only five lots.
It was a private label drug which was being sold by Walmart and some others under different brands including Equate.
Dr Reddy’s scrip gained 3.19 per cent on the Bombay Stock Exchange on Thursday to close at Rs 2,110.40.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.